-+ 0.00%
-+ 0.00%
-+ 0.00%

Jones Trading Downgrades Intellia Therapeutics to Hold

Benzinga·11/11/2025 19:54:11
Listen to the news
Jones Trading analyst Debanjana Chatterjee downgrades Intellia Therapeutics (NASDAQ:NTLA) from Buy to Hold.